Sfoglia per Rivista CANCER
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial
2009-01-01 Vincenzi, B; Santini, D; Russo, A; Spoto, C; Venditti, O; Gasparro, S; Rizzo, S; Beomonte Zobel, B; Caricato, M; Valeri, S; Coppola, R; Tonini, G.
Cancer chronotherapy: Principles, applications, and perspectives
2003-01-01 Vincenzi, B; Santini, D; La Cesa, A; Tonini, G
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
2020-01-01 D'Ambrosio, L; Touati, N; Blay, Jy; Grignani, G; Flippot, R; Czarnecka, Am; Piperno-Neumann, S; Martin-Broto, J; Sanfilippo, R; Katz, D; Duffaud, F; Vincenzi, B; Stark, Dp; Mazzeo, F; Tuchscherer, A; Chevreau, C; Sherriff, J; Estival, A; Liti?re, S; Sents, W; Ray-Coquard, I; Tolomeo, F; Le Cesne, A; Rutkowski, P; Stacchiotti, S; Kasper, B; Gelderblom, H; Gronchi, A
Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study
2000-01-01 BENEDETTI-PANICI, P; Maneschi, F; D'Andrea, G; Cutillo, G; Rabitti, C; Congiu, M; Coronetta, F; Capelli, A
ENHANCEMENT OF PROGESTERONE-RECEPTOR LEVELS BY INTERFERONS IN AE-7 ENDOMETRIAL CANCER-CELLS
1993-01-01 Angioli, R; Untch, M; Sevin, Bu; Steren, A; Hightower, Rd; Perras, Jp; Nguyen, Hn; Koechli, Or; Averette, He
Expression of the Embryonic Lethal Abnormal Vision-like Protein HuR in Human Mesothelioma Association With Cyclooxygenase-2 and Prognosis
2008-01-01 Stoppoloni, D; Cardillo, I; Verdina, A; Vincenzi, B; Menegozzo, S; Santini, M; Sacchi, A; Baldi, A; Galati, R
GLUT-1 expression in ovarian carcinoma - Association with survival and response to chemotherapy
2001-01-01 Cantuaria, G; Fagotti, A; Ferrandina, G; Magalhaes, A; Nadji, M; Angioli, R; Penalver, M; Mancuso, S; Scambia, G
How to reduce the impact of cervical cancer worldwide: Gaps and priority areas identified through the essential cancer and primary care packages: An analysis of effective interventions
2020-01-01 Gatti, Alessandra; Haruyama, Rei; Elit, Laurie; Howard, Scott C; Lam, Catherine G; Ilbawi, Andre; Angioli, Roberto; Cao, Xueyuan; Fidarova, Elena
In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell lines
1993-01-01 Angioli, R; Sevin, Bu; Perras, Jp; Untch, M; Koechli, Or; Nguyen, Hn; Steren, A; Schwade, Jg; Villani, C; Averette, He.
Long-term bladder function in patients with locally advanced cervical carcinoma treated with neoadjuvant chemotherapy and type 3-4 radical hysterectomy
2004-01-01 Benedetti-Panici, P; Zullo, Ma; Plotti, F; Manci, N; Muzii, L; Angioli, R
Neoadiuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factots for response and survival
1991-01-01 BENEDETTI-PANICI, P.; Scambia, G.; Baiocchi, G.; Greggi, S.; Rabitti, C
Phase 2 Trial of Temozolomide Using Protracted Low-dose and Whole-brain Radiotherapy for Nonsmall Cell Lung Cancer and Breast Cancer Patients With Brain Metastases
2008-01-01 Addeo, R; De Rosa, C; Faiola, V; Leo, L; Cennamo, G; Montella, L; Guarrasi, R; Vincenzi, B; Caraglia, M; Del Prete, S
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network
2019-01-01 Frezza, Am; Assi, T; Lo Vullo, S; Ben-Ami, E; Dufresne, A; Yonemori, K; Noguchi, E; Siontis, B; Ferraro, R; Teterycz, P; Duffaud, F; Ravi, V; Vincenzi, B; Gelderblom, H; Pantaleo, Ma; Baldi, Gg; Desar, I; Fedenko, A; Maki, Rg; Jones, Rl; Benjamin, Rs; Blay, Jy; Kawai, A; Gounder, M; Gronchi, A; Le Cesne, A; Mir, O; Czarnecka, Am; Schuetze, S; Wagner, Aj; Adam, J; Barisella, M; Sbaraglia, M; Hornick, Jl; Meurgey, A; Mariani, L; Casali, Pg; Thornton, K; Stacchiotti, S
Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases - Survey by outcome research network for evaluation of treatment results in oncology
2007-01-01 Moscetti, L; Nelli, F; Felici, A; Rinaldi, M; De Santis, S; D'Auria, G; Mansueto, G; Tonini, G; Sperduti, I; Pollera, Fc
Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma.
2002-01-01 Berruti, Alfredo; Tucci, M; Dogliotti, Luigi; Scarpa, Roberto Mario; Angeli, Alberto
Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case-series analysis from the Italian Rare Cancers Network
2022-01-01 Baldi, Giacomo G; Lo Vullo, Salvatore; Grignani, Giovanni; Vincenzi, Bruno; Badalamenti, Giuseppe; Mastore, Marinella; Buonomenna, Ciriaco; Morosi, Carlo; Barisella, Marta; Frezza, Anna Maria; Provenzano, Salvatore; Simeone, Noemi; Picozzi, Fernanda; Mariani, Luigi; Casali, Paolo G; Stacchiotti, Silvia
Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma
2004-01-01 Vincenzi, B; Santini, D; La Cesa, A; Tonini, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial | 1-gen-2009 | Vincenzi, B; Santini, D; Russo, A; Spoto, C; Venditti, O; Gasparro, S; Rizzo, S; Beomonte Zobel, B; Caricato, M; Valeri, S; Coppola, R; Tonini, G. | |
| Cancer chronotherapy: Principles, applications, and perspectives | 1-gen-2003 | Vincenzi, B; Santini, D; La Cesa, A; Tonini, G | |
| Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group | 1-gen-2020 | D'Ambrosio, L; Touati, N; Blay, Jy; Grignani, G; Flippot, R; Czarnecka, Am; Piperno-Neumann, S; Martin-Broto, J; Sanfilippo, R; Katz, D; Duffaud, F; Vincenzi, B; Stark, Dp; Mazzeo, F; Tuchscherer, A; Chevreau, C; Sherriff, J; Estival, A; Liti?re, S; Sents, W; Ray-Coquard, I; Tolomeo, F; Le Cesne, A; Rutkowski, P; Stacchiotti, S; Kasper, B; Gelderblom, H; Gronchi, A | |
| Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study | 1-gen-2000 | BENEDETTI-PANICI, P; Maneschi, F; D'Andrea, G; Cutillo, G; Rabitti, C; Congiu, M; Coronetta, F; Capelli, A | |
| ENHANCEMENT OF PROGESTERONE-RECEPTOR LEVELS BY INTERFERONS IN AE-7 ENDOMETRIAL CANCER-CELLS | 1-gen-1993 | Angioli, R; Untch, M; Sevin, Bu; Steren, A; Hightower, Rd; Perras, Jp; Nguyen, Hn; Koechli, Or; Averette, He | |
| Expression of the Embryonic Lethal Abnormal Vision-like Protein HuR in Human Mesothelioma Association With Cyclooxygenase-2 and Prognosis | 1-gen-2008 | Stoppoloni, D; Cardillo, I; Verdina, A; Vincenzi, B; Menegozzo, S; Santini, M; Sacchi, A; Baldi, A; Galati, R | |
| GLUT-1 expression in ovarian carcinoma - Association with survival and response to chemotherapy | 1-gen-2001 | Cantuaria, G; Fagotti, A; Ferrandina, G; Magalhaes, A; Nadji, M; Angioli, R; Penalver, M; Mancuso, S; Scambia, G | |
| How to reduce the impact of cervical cancer worldwide: Gaps and priority areas identified through the essential cancer and primary care packages: An analysis of effective interventions | 1-gen-2020 | Gatti, Alessandra; Haruyama, Rei; Elit, Laurie; Howard, Scott C; Lam, Catherine G; Ilbawi, Andre; Angioli, Roberto; Cao, Xueyuan; Fidarova, Elena | |
| In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell lines | 1-gen-1993 | Angioli, R; Sevin, Bu; Perras, Jp; Untch, M; Koechli, Or; Nguyen, Hn; Steren, A; Schwade, Jg; Villani, C; Averette, He. | |
| Long-term bladder function in patients with locally advanced cervical carcinoma treated with neoadjuvant chemotherapy and type 3-4 radical hysterectomy | 1-gen-2004 | Benedetti-Panici, P; Zullo, Ma; Plotti, F; Manci, N; Muzii, L; Angioli, R | |
| Neoadiuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factots for response and survival | 1-gen-1991 | BENEDETTI-PANICI, P.; Scambia, G.; Baiocchi, G.; Greggi, S.; Rabitti, C | |
| Phase 2 Trial of Temozolomide Using Protracted Low-dose and Whole-brain Radiotherapy for Nonsmall Cell Lung Cancer and Breast Cancer Patients With Brain Metastases | 1-gen-2008 | Addeo, R; De Rosa, C; Faiola, V; Leo, L; Cennamo, G; Montella, L; Guarrasi, R; Vincenzi, B; Caraglia, M; Del Prete, S | |
| Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network | 1-gen-2019 | Frezza, Am; Assi, T; Lo Vullo, S; Ben-Ami, E; Dufresne, A; Yonemori, K; Noguchi, E; Siontis, B; Ferraro, R; Teterycz, P; Duffaud, F; Ravi, V; Vincenzi, B; Gelderblom, H; Pantaleo, Ma; Baldi, Gg; Desar, I; Fedenko, A; Maki, Rg; Jones, Rl; Benjamin, Rs; Blay, Jy; Kawai, A; Gounder, M; Gronchi, A; Le Cesne, A; Mir, O; Czarnecka, Am; Schuetze, S; Wagner, Aj; Adam, J; Barisella, M; Sbaraglia, M; Hornick, Jl; Meurgey, A; Mariani, L; Casali, Pg; Thornton, K; Stacchiotti, S | |
| Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases - Survey by outcome research network for evaluation of treatment results in oncology | 1-gen-2007 | Moscetti, L; Nelli, F; Felici, A; Rinaldi, M; De Santis, S; D'Auria, G; Mansueto, G; Tonini, G; Sperduti, I; Pollera, Fc | |
| Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma. | 1-gen-2002 | Berruti, Alfredo; Tucci, M; Dogliotti, Luigi; Scarpa, Roberto Mario; Angeli, Alberto | |
| Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case-series analysis from the Italian Rare Cancers Network | 1-gen-2022 | Baldi, Giacomo G; Lo Vullo, Salvatore; Grignani, Giovanni; Vincenzi, Bruno; Badalamenti, Giuseppe; Mastore, Marinella; Buonomenna, Ciriaco; Morosi, Carlo; Barisella, Marta; Frezza, Anna Maria; Provenzano, Salvatore; Simeone, Noemi; Picozzi, Fernanda; Mariani, Luigi; Casali, Paolo G; Stacchiotti, Silvia | |
| Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma | 1-gen-2004 | Vincenzi, B; Santini, D; La Cesa, A; Tonini, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile